| Not Yet Recruiting | A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thro NCT05900388 | Bayer | — |
| Not Yet Recruiting | Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study) NCT07499661 | University Hospital, Angers | N/A |
| Not Yet Recruiting | Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Mu NCT07506473 | University Hospital, Grenoble | N/A |
| Not Yet Recruiting | Statins to Prevent Cancer Associated Blood Clots NCT07303816 | Brigham and Women's Hospital | Phase 4 |
| Recruiting | Aspiration Thrombectomy Using the Symphony or Prodigy System NCT07350499 | Imperative Care, Inc. | — |
| Recruiting | Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism NCT07399977 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic NCT06861088 | Quercis Pharma AG | Phase 3 |
| Active Not Recruiting | Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery NCT07455253 | Affiliated Hospital of Nantong University | — |
| Recruiting | Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER ) NCT06731244 | University Hospital, Brest | N/A |
| Not Yet Recruiting | Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism NCT06382038 | Navy General Hospital, Beijing | N/A |
| Not Yet Recruiting | Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for NCT07213713 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Apixaban or Enoxaparin After Head and Neck Cancer Surgery NCT07189897 | Kiranya Arnold | Phase 4 |
| Enrolling By Invitation | Implementing VTE Prevention in Ambulatory Cancer Care NCT07292376 | University of Vermont | N/A |
| Not Yet Recruiting | Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study NCT07196020 | University of Dublin, Trinity College | — |
| Recruiting | A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA NCT07140523 | Sirius Therapeutics Co., Ltd. | Phase 2 |
| Not Yet Recruiting | Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma NCT06580223 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 3 |
| Recruiting | CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism NCT04211181 | China-Japan Friendship Hospital | N/A |
| Recruiting | Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) NCT06440694 | Ottawa Hospital Research Institute | Phase 3 |
| Recruiting | Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study NCT05881798 | Cook Research Incorporated | — |
| Recruiting | Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis NCT06958588 | Science Valley Research Institute | Phase 4 |
| Not Yet Recruiting | The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity NCT06494878 | University of Calgary | Phase 3 |
| Completed | The Protrieve PROTECTOR Study NCT06495996 | Inari Medical | N/A |
| Recruiting | Variations in the Hemostatic System Induced by a Standardized Walking Test NCT06418633 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Active Not Recruiting | An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Co NCT06765681 | Bayer | — |
| Suspended | CLEANer Aspiration for Pulmonary Embolism NCT06189313 | Argon Medical Devices | N/A |
| Recruiting | Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis NCT06603870 | Ottawa Hospital Research Institute | Phase 4 |
| Active Not Recruiting | Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE) NCT06815874 | University Hospital, Brest | — |
| Recruiting | inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Under NCT06581965 | Leiden University Medical Center | Phase 4 |
| Recruiting | Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism NCT06393868 | Ottawa Hospital Research Institute | Phase 3 |
| Recruiting | VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy NCT05920343 | Ottawa Hospital Research Institute | Phase 2 / Phase 3 |
| Not Yet Recruiting | Smart Technology Facilitated Patient-centered Venous Thromboembolism Management NCT06350344 | Navy General Hospital, Beijing | N/A |
| Recruiting | Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage NCT06753786 | Pirogov Russian National Research Medical University | N/A |
| Completed | A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adu NCT06299111 | Regeneron Pharmaceuticals | Phase 2 |
| Unknown | Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Str NCT06353373 | Navy General Hospital, Beijing | — |
| Enrolling By Invitation | Smart Technology Facilitated Patient-centered Venous Thromboembolism Management NCT06350331 | Navy General Hospital, Beijing | N/A |
| Recruiting | RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing NCT06195540 | University Hospital, Angers | Phase 3 |
| Recruiting | Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery NCT06451003 | Medical University of South Carolina | N/A |
| Completed | A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Particip NCT06454630 | Regeneron Pharmaceuticals | Phase 2 |
| Recruiting | Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict NCT06372730 | University Hospital, Brest | N/A |
| Recruiting | Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959 | Clinical Urology and Epidemiology Working Group | Phase 4 |
| Withdrawn | SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery NCT05104229 | Stefan Holubar MD MS FACS, FASCRS | Phase 3 |
| Not Yet Recruiting | TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism NCT06452342 | University Health Network, Toronto | Phase 4 |
| Recruiting | Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring Immobilis NCT06416280 | University Hospital, Angers | — |
| Recruiting | CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - NCT07328152 | University Hospital, Brest | — |
| Suspended | Glioblastoma Remote Monitoring and Care - Research Protocol NCT06129760 | Case Comprehensive Cancer Center | N/A |
| Recruiting | GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprop NCT06166537 | Imperial College London | N/A |
| Terminated | A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 M NCT05966740 | Boehringer Ingelheim | — |
| Recruiting | The Gynecological Cancer Associated Thrombosis (GynCAT) Study NCT06284343 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Unknown | 5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders NCT06302478 | Khon Kaen University | N/A |
| Completed | Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Service NCT06445283 | Hacettepe University | — |
| Completed | An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Ve NCT06278051 | Bayer | — |
| Recruiting | THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) NCT05735639 | Imperial College London | Phase 4 |
| Completed | Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF) NCT07165587 | Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu | — |
| Withdrawn | The Effect of Sock Developed with Wearable Technology for TUR Surgery Patients on Hypothermia and Venous Throm NCT05887518 | Tarsus University | N/A |
| Unknown | Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease NCT02877251 | Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa | — |
| Recruiting | The Role of Platelet TLRs in Platelet Activation During VTE NCT06257290 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Unknown | Chinese Community Inpatient Thromboembolism NCT06168331 | RenJi Hospital | — |
| Recruiting | Supplemental Oxygen in Pulmonary Embolism (SO-PE) NCT05891886 | Massachusetts General Hospital | EARLY_Phase 1 |
| Enrolling By Invitation | Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism NCT05794165 | Bryan Cotton | Phase 2 |
| Unknown | Venous Thromboembolism in Primary Pancreatic Tumour Resection NCT05964621 | University of Thessaly | — |
| Recruiting | GEKO Venous Thromboembolism Prevention Study NCT05476913 | Firstkind Ltd | N/A |
| Unknown | Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State NCT05939960 | Tianjin Medical University General Hospital | — |
| Completed | A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Pa NCT05618808 | Regeneron Pharmaceuticals | Phase 2 |
| Recruiting | Evaluation of the SCALED (SCaling AcceptabLE cDs) NCT05628207 | University of Minnesota | — |
| Unknown | Pregnancy and Postpartum Period Venous Thromboembolism and Simulation NCT06218095 | Saglik Bilimleri Universitesi | N/A |
| Terminated | Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Pop NCT05819125 | Sanofi | — |
| Terminated | A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) f NCT05819112 | Sanofi | — |
| Recruiting | PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism NCT05756244 | University of Calgary | — |
| Unknown | Study of Low Molecular Weight Heparins NCT06020560 | Herlev Hospital | Phase 4 |
| Recruiting | Warfarin Patient Self-management Implementation in the US Healthcare System NCT04766216 | University of Utah | N/A |
| Unknown | Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery NCT05860790 | Capital Medical University | — |
| Completed | Treatment Patterns Among Patients With Venous Thromboembolism in the United States NCT05795062 | Pfizer | — |
| Unknown | Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty NCT05449327 | Chiayi Christian Hospital | N/A |
| Recruiting | Venous Thromboembolism Prevention in Outpatients With Glioma NCT05683808 | University of Vermont Medical Center | Phase 2 |
| Recruiting | DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis NCT05701917 | Inari Medical | N/A |
| Withdrawn | A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of NCT05536791 | Boehringer Ingelheim | — |
| Completed | Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical C NCT05208216 | Manchester University NHS Foundation Trust | N/A |
| Recruiting | Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters NCT05029063 | Ottawa Hospital Research Institute | Phase 3 |
| Recruiting | DOAC in Chinese Patients With Atrial Fibrillation NCT05378035 | Chinese University of Hong Kong | — |
| Terminated | A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Assoc NCT05171075 | Anthos Therapeutics, Inc. | Phase 3 |
| Unknown | Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-ri NCT05347550 | Imperial College London | N/A |
| Completed | Thrombosis in Patients With Multiple Myeloma in an University Medical Center NCT05541978 | Catalina Codreanu | — |
| Completed | Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use NCT05351749 | University of Michigan | N/A |
| Completed | An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is C NCT05461807 | Bayer | — |
| Recruiting | Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support NCT06480994 | Diagnostica Stago R&D | — |
| Terminated | THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) NCT05033314 | University Health Network, Toronto | Phase 3 |
| Recruiting | NOACs Use in AF or VTE (SUNSHINE Registry) NCT05378308 | Henan Provincial People's Hospital | — |
| Unknown | Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism NCT05382481 | Xuanwu Hospital, Beijing | N/A |
| Terminated | A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE NCT05171049 | Anthos Therapeutics, Inc. | Phase 3 |
| Completed | Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial NCT05878899 | University Hospital, Geneva | Phase 3 |
| Completed | Efficacy of ICU-VTE Scale in ICU Patients NCT05487066 | Lijuan Zhang | — |
| Completed | Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO NCT04846556 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism NCT02828904 | Center for Epidemiology and Health Research, Germany | — |
| Unknown | Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy NCT05108389 | Nottingham University Hospitals NHS Trust | — |
| Unknown | Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer NCT05240508 | University of Vermont | — |
| Completed | anti10a Levels in Women Treated With LMWH in the Postpartum Period NCT02856295 | HaEmek Medical Center, Israel | Phase 4 |
| Completed | Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients NCT05226793 | Methodist Health System | — |
| Completed | Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications NCT05143567 | Ryazan State Medical University | N/A |
| Completed | Use of Tranexamic Acid in Reduction Mammoplasty NCT04947514 | Montefiore Medical Center | Phase 4 |
| Completed | Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study NCT05897697 | Marc Blondon | — |
| Unknown | Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease NCT03935451 | McMaster University | EARLY_Phase 1 |
| Completed | Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea NCT05022563 | Pfizer | — |
| Completed | Low Molecular Weight hEparin vs. Aspirin Post-partum NCT05058924 | Mount Sinai Hospital, Canada | N/A |
| Recruiting | Impact of COVID-19 Vaccines on Cerebrovascular Health NCT04992195 | Chinese University of Hong Kong | — |
| Withdrawn | Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Pro NCT03988231 | University of Utah | Phase 4 |
| Completed | The Incidence of Venous Thromboembolism in Atopic Dermatitis NCT04969653 | Momentum Data | — |
| Active Not Recruiting | Leiden Thrombosis Recurrence Risk Prevention NCT06087952 | Leiden University Medical Center | N/A |
| Completed | Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thro NCT04920487 | Fondation Hôpital Saint-Joseph | — |
| Completed | OsciPulse Device for the Prevention of VTE NCT04625673 | University of Pennsylvania | N/A |
| Completed | Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data NCT05264168 | Brigham and Women's Hospital | — |
| Completed | Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment NCT04744688 | University of Aarhus | — |
| Completed | the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients NCT04963374 | Peking University Third Hospital | — |
| Recruiting | Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fond NCT04539301 | Nantes University Hospital | — |
| Recruiting | Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients NCT06194617 | Peking Union Medical College Hospital | — |
| Completed | Clotting Parameters After Medical Abortion NCT04824118 | NHS Lothian | — |
| Unknown | A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay NCT04737954 | LumiraDx UK Limited | N/A |
| Recruiting | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty NCT04295486 | University of Miami | Phase 2 |
| Terminated | Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. NCT04710732 | Pirogov Russian National Research Medical University | Phase 4 |
| Completed | Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thro NCT04168203 | Brigham and Women's Hospital | Phase 4 |
| Completed | Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery NCT04479579 | McMaster University | Phase 4 |
| Recruiting | Statins for Venous Event Reduction in Patients With Venous Thromboembolism NCT04319627 | Ottawa Hospital Research Institute | Phase 3 |
| Completed | Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 NCT05185804 | PharmaDiall Ltd. | Phase 3 |
| Recruiting | VTE Prevention Following Total Hip and Knee Arthroplasty NCT04075240 | Sudeep Shivakumar | Phase 3 |
| Completed | Venous Thrombo-Embolism Imaging Database (VTE-ID) NCT06258694 | University Hospital, Brest | — |
| Completed | Venous Thrombosis Virtual Surveillance in COVID-19 NCT04865913 | Ottawa Hospital Research Institute | — |
| Completed | Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events NCT05515120 | Instituto Mexicano del Seguro Social | Phase 2 / Phase 3 |
| Unknown | LMWH Compliance in Pregnancy NCT05066867 | Cork University Maternity Hospital | — |
| Recruiting | Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) NCT04257487 | Arianna Anticoagulazione Foundation | Phase 3 |
| Completed | A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboe NCT04768036 | Northwell Health | N/A |
| Completed | Examining the Experiences of Children With Blood Disorders NCT04600609 | University of Texas Southwestern Medical Center | — |
| Completed | Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events NCT04574895 | Vanderbilt University Medical Center | N/A |
| Completed | Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients NCT05926518 | Rijnstate Hospital | — |
| Unknown | Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin NCT04999176 | André Luiz Malavasi Longo de Oliveira | Phase 3 |
| Completed | Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The NCT04662684 | Science Valley Research Institute | Phase 3 |
| Completed | Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity NCT04153760 | University of Calgary | EARLY_Phase 1 |
| Completed | Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data NCT04736719 | Brigham and Women's Hospital | — |
| Completed | Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data NCT04735523 | Brigham and Women's Hospital | — |
| Completed | Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data NCT04736420 | Brigham and Women's Hospital | — |
| Unknown | Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement NCT05306821 | Marc Blondon | N/A |
| Completed | Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait NCT04349189 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT NCT04504318 | Stanford University | Phase 1 / Phase 2 |
| Completed | Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemother NCT04352439 | Duke University | Phase 4 |
| Completed | Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial NCT04409834 | The TIMI Study Group | Phase 4 |
| Completed | Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phe NCT04444804 | Bayer | — |
| Completed | Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism NCT04477564 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients NCT04439383 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptio NCT04064489 | University Hospital, Angers | N/A |
| Completed | Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic NCT04400877 | University Hospital, Linkoeping | — |
| Unknown | Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospecti NCT05229471 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Effect of the Genotype on Postoperative DVT NCT04940377 | Rigshospitalet, Denmark | — |
| Recruiting | Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism NCT04263038 | Drahomir Aujesky | Phase 4 |
| Recruiting | Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters NCT04066764 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 3 |
| Completed | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 NCT04374617 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Completed | Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) NCT04335162 | Centre Hospitalier Universitaire de Nice | — |
| Terminated | The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) NCT03977363 | CHAD | — |
| Unknown | Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban NCT04169269 | Florida Orthopaedic Institute | Phase 4 |
| Completed | A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunte NCT04157881 | Population Health Research Institute | Phase 4 |
| Unknown | A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent NCT04128254 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
| Completed | COVID-19 and Venous Thromboembolism Risk NCT04569344 | University of California, San Francisco | — |
| Unknown | Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Veno NCT04141254 | University Hospital, Brest | Phase 3 |
| Completed | LEAVE Safe With DOACs NCT04068727 | University of Massachusetts, Worcester | N/A |
| Completed | The Affect Of An Anti-Embolism Stocking Protocol NCT06616376 | Cukurova University | N/A |
| Unknown | Thrombus Elastography in Venous Thrombo-Embolism. NCT04130048 | University Hospital, Brest | — |
| Completed | Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event NCT03988101 | Yonsei University | Phase 4 |
| Completed | Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians NCT04272723 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry NCT04195113 | McMaster University | — |
| Completed | Improving Safety of Diagnosis and Therapy in the Inpatient Setting NCT04393909 | Brigham and Women's Hospital | N/A |
| Unknown | A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement NCT05189002 | PharmaDiall Ltd. | Phase 2 |
| Terminated | PET Fibrin Imaging of DVT and PE NCT04022915 | Peter Caravan | Phase 1 |
| Terminated | Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy Wi NCT04106700 | Instituto de Investigacion Sanitaria La Fe | Phase 2 |
| Completed | Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Repl NCT03812328 | Tetherex Pharmaceuticals Corporation | Phase 2 |
| Completed | The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort St NCT03835780 | Momentum Data | — |
| Recruiting | Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of C NCT03728166 | Brigham and Women's Hospital | N/A |
| Completed | A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers NCT03919890 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients NCT06556953 | Haike Lei | — |
| Recruiting | Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune NCT06950697 | Beijing Chao Yang Hospital | — |
| Unknown | Development and Validation of the Patient-completed Caprini Risk Score NCT04663477 | China-Japan Friendship Hospital | — |
| Completed | Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives NCT03949985 | University Hospital, Geneva | — |
| Unknown | Safety and Efficacy Study of Fitaya Vena Cava Filter NCT03691753 | Lifetech Scientific (Shenzhen) Co., Ltd. | N/A |
| Terminated | Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) NCT03090880 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Unknown | Swedish Multicenter Trial of Outpatient Prevention of Leg Clots NCT03259204 | Karolinska University Hospital | N/A |
| Unknown | Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic NCT03580577 | Assiut University | — |
| Terminated | Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding NCT04748393 | Leiden University Medical Center | — |
| Terminated | Apixaban for Extended Anticoagulation (APIDULCIS) NCT03678506 | Arianna Anticoagulazione Foundation | Phase 4 |
| Completed | Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study) NCT05209048 | Beijing Tsinghua Chang Gung Hospital | — |
| Terminated | Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism NCT03196349 | Duke University | Phase 4 |
| Withdrawn | Detecting Circulating Emboli in Patients with Acute Venous Thromboembolism NCT02735759 | University of Arkansas | N/A |
| Unknown | Venous Thromboembolism in Advanced Lung Cancer NCT03581708 | Guangdong Provincial People's Hospital | — |
| Terminated | ThRombosis ExclUsion STudy NCT03477968 | Diagnostica Stago | — |
| Completed | Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer NCT03646409 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients NCT04257305 | Huashan Hospital | — |
| Unknown | Allo - Cancer - Thrombosis NCT03563924 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study) NCT05058521 | Beijing Tsinghua Chang Gung Hospital | — |
| Unknown | The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Sa NCT04179487 | University College Dublin | — |
| Completed | Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions NCT02898090 | University Hospital, Bordeaux | — |
| Active Not Recruiting | LIFE - Lung Cancer, Immunotherapy, Frailty, Effect NCT03870464 | University of Southern Denmark | — |
| Completed | Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin NCT03516656 | University of Utah | EARLY_Phase 1 |
| Terminated | WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboemb NCT03297359 | Ottawa Hospital Research Institute | Phase 2 |
| Unknown | Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring NCT03426982 | Wuhan Asia Heart Hospital | Phase 4 |
| Completed | Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma NCT02958969 | Gregory Piazza | Phase 4 |
| Enrolling By Invitation | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology NCT03244020 | Massachusetts General Hospital | Phase 4 |
| Completed | WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? NCT04646993 | Arianna Anticoagulazione Foundation | — |
| Completed | Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 I NCT06806800 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair. NCT05439187 | Pirogov Russian National Research Medical University | — |
| Completed | Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism NCT03266783 | Ottawa Hospital Research Institute | Phase 4 |
| Completed | Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients NCT03243708 | The Cleveland Clinic | N/A |
| Completed | Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma NCT03339349 | University of Utah | Phase 2 |
| Completed | REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. NCT03285438 | University Hospital, Brest | Phase 3 |
| Unknown | Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD NCT03277001 | Huashan Hospital | N/A |
| Completed | Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients NCT03251963 | University of Utah | Phase 2 |
| Unknown | A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism NCT03240120 | The University of Hong Kong | Phase 3 |
| Terminated | Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury NCT03200613 | McMaster University | Phase 2 |
| Completed | Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism NCT03404635 | Indiana University | — |
| Completed | Distribution of Risk Factors for Venous Thromboembolism in Blood Donors NCT03282747 | Casa Sollievo della Sofferenza IRCCS | — |
| Completed | Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associate NCT03214172 | Bayer | — |
| Completed | Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) NCT03054727 | Association des Médecins Vasculaires Hospitaliers | — |
| Completed | Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection NCT03115541 | McMaster University | — |
| Completed | Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery NCT03212365 | University of Utah | Phase 2 |
| Completed | RIPT Feasibility Trial NCT03070834 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Terminated | PREvention of VENous ThromboEmbolism Following Radical Prostatectomy NCT03006562 | Johns Hopkins University | Phase 4 |
| Terminated | Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia NCT03195010 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism NCT04041843 | New York Medical College | Phase 2 |
| Completed | Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus NCT03083782 | Thomas Jefferson University | Phase 1 |
| Completed | Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer NCT03045406 | Fadoi Foundation, Italy | Phase 3 |
| Completed | Hemostatic Profiles of Endocrine Therapies for Breast Cancer NCT03381963 | University Hospital, Geneva | — |
| Completed | Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (E NCT02952599 | Daiichi Sankyo | — |
| Completed | Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery NCT03475771 | Fondation Hôpital Saint-Joseph | — |
| Unknown | SToP: Venous Thromboembolism Screening in the Trauma Population NCT02978950 | Intermountain Health Care, Inc. | N/A |
| Recruiting | Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboemb NCT03781531 | Danderyd Hospital | — |
| Terminated | Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis NCT02945280 | Intermountain Health Care, Inc. | Phase 4 |
| Withdrawn | Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxab NCT02900404 | Bayer | — |
| Completed | Venous Thrombo-embolic Complication prévention in Pelvic Surgery NCT03535428 | Fondation Hôpital Saint-Joseph | — |
| Terminated | STAT-STatin and Aspirin in Trauma NCT02901067 | Denver Health and Hospital Authority | Phase 2 |
| Completed | Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism NCT03044574 | Pirogov Russian National Research Medical University | N/A |
| Completed | Microsurgical Breast Reconstruction & VTE NCT03031457 | Stanford University | — |
| Completed | Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis NCT03309293 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism NCT02713581 | Centre Hospitalier Universitaire de Nīmes | — |
| Recruiting | Caprini Score in Venous Surgery: a Prospective Cohort Study NCT03041805 | Pirogov Russian National Research Medical University | — |
| Completed | An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwa NCT03799016 | Bayer | — |
| Completed | Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer NCT02744092 | Alliance Foundation Trials, LLC. | N/A |
| Completed | Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin NCT02970032 | University of Utah | EARLY_Phase 1 |
| Completed | Edoxaban Management in Diagnostic and Therapeutic Procedures NCT02950168 | Daiichi Sankyo | — |
| Unknown | StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study NCT02679664 | Ottawa Hospital Research Institute | Phase 2 |
| Completed | Anticoagulation Medical Home NCT02870296 | University of Massachusetts, Worcester | N/A |
| Unknown | Multiple Algorithms System Of All Scores in Embolism (MOSE) NCT02911012 | University Magna Graecia | — |
| Completed | Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban NCT02746185 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants NCT02912234 | Bristol-Myers Squibb | Phase 1 |
| Completed | RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding NCT02829957 | Indiana University | Phase 2 / Phase 3 |
| Completed | ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE NCT02836457 | Bristol-Myers Squibb | — |
| Completed | Tumor-educated Platelets in Venous Thromboembolism NCT02739867 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery NCT02474212 | Tampere University Hospital | Phase 4 |
| Completed | Thrombosis Outcomes in Pediatric Venous Thromboembolism NCT03068923 | University of Texas Southwestern Medical Center | — |
| Completed | Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study NCT02559856 | Ottawa Hospital Research Institute | Phase 4 |
| Completed | Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe NCT02943993 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Terminated | Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients NCT02583191 | AIO-Studien-gGmbH | Phase 3 |
| Completed | Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxa NCT02704052 | University of Utah | EARLY_Phase 1 |
| Completed | Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients NCT02412982 | University of Cincinnati | Phase 4 |
| Withdrawn | Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically NCT02707263 | NYU Langone Health | N/A |
| Completed | Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients NCT02687204 | University of Utah | Phase 1 |
| Unknown | Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose NCT02486666 | Hamilton Health Sciences Corporation | Phase 3 |
| Completed | VTE Prophylaxis Guidelines in Hospitalized Elders NCT03025100 | Duke University | — |
| Terminated | Aspirin and Enoxaparin for VTE in Trauma NCT02396732 | University of Miami | Phase 4 |
| Recruiting | Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT NCT06714734 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Thromboprophylaxis After Surgery for Gynecologic Malignancy in China NCT02935530 | Huazhong University of Science and Technology | Phase 3 |
| Completed | A Different Approach to Preventing Thrombosis NCT02774265 | University of Maryland, Baltimore | Phase 3 |
| Withdrawn | Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System NCT02420626 | Volcano Corporation | — |
| Completed | Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease NCT03134820 | Delos Clinical | — |
| Completed | Treatment of Venous Thromboembolism in Real-Life Patients NCT03087474 | Bristol-Myers Squibb | — |
| Completed | Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS NCT02546817 | Bristol-Myers Squibb | — |
| Completed | Apixaban for the Acute Treatment of Venous Thromboembolism in Children NCT02464969 | Bristol-Myers Squibb | Phase 4 |
| Completed | Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism NCT02585713 | Academic and Community Cancer Research United | Phase 3 |
| Completed | Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) NCT02558465 | Bayer | — |
| Completed | RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism NCT02596230 | Boehringer Ingelheim | — |
| Completed | Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function NCT03158792 | Lebanese American University | Phase 4 |
| Unknown | Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection NCT02503904 | Klein, Jeffrey A., M.D. | Phase 2 / Phase 3 |
| Completed | The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Stud NCT02379806 | University Hospital, Brest | Phase 3 |
| Completed | Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery NCT02334007 | McMaster University | Phase 1 / Phase 2 |
| Completed | Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism NCT03099031 | LEO Pharma | — |
| Unknown | Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study) NCT02160964 | Heart and Vascular Outcomes Research Institute | — |
| Completed | Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Mali NCT02366871 | University of Colorado, Denver | Phase 2 |
| Completed | Education Bundle to Decrease Patient Refusal of VTE Prophylaxis NCT02402881 | Johns Hopkins University | N/A |
| Completed | Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered NCT02969343 | Brigham and Women's Hospital | N/A |
| Unknown | Predicting the Risk of Venous Thromboembolism in Critically Ill Patients NCT05498142 | University Medical Center Groningen | — |
| Completed | Direct Oral Anticoagulants and Venous Thromboembolism NCT02833987 | Canadian Network for Observational Drug Effect Studies, CNODES | — |
| Completed | Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients NCT03124017 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Enoxaparin Metabolism in Reconstructive Surgery Patients NCT02411292 | University of Utah | Phase 2 |
| Completed | Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery NCT01308528 | Cristália Produtos Químicos Farmacêuticos Ltda. | Phase 3 |
| Unknown | Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards NCT03157843 | University of Roma La Sapienza | — |
| Completed | EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis NCT02309411 | Bayer | Phase 2 |
| Completed | Haemorrhages and Thromboembolic Venous Disease of the Postpartum NCT02443610 | University Hospital, Brest | — |
| Completed | Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery NCT06302179 | Pirogov Russian National Research Medical University | — |
| Completed | Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome NCT05195372 | Cardioangiologisches Centrum Bethanien | — |
| Completed | The Angel® Catheter Pivotal Clinical Trial NCT02186223 | BiO2 Medical | N/A |
| Terminated | Statin Use in Patients With Acute VTE NCT02331095 | Ohio State University | EARLY_Phase 1 |
| Completed | Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) NCT02297373 | Ottawa Hospital Research Institute | — |
| Completed | EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis NCT02234843 | Bayer | Phase 3 |
| Completed | Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study NCT02303431 | Daiichi Sankyo | Phase 1 |
| Unknown | Venous Thromboembolic Complications in Ovarian Cancer NCT02480790 | Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | — |
| Completed | Follow-up in Rivaroxaban Patients in Setting of Thromboembolism NCT02248610 | King's College Hospital NHS Trust | — |
| Completed | Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty NCT02271399 | Hanyang University Seoul Hospital | Phase 2 |